The U.S. medical spa market hit $21.21 billion in 2024 and is projected to reach $78.23 billion by 2033, a 15.77% compound annual growth rate that almost no other consumer-services category can match (Grand View Research). The number of locations is climbing just as fast — AmSpa counted 8,899 U.S. med spas in 2022 and 10,488 by 2023, a 17.9% jump in a single year (Scope Research, 2025).
But that headline number hides the operating story underneath it. Per AmSpa’s 2024 State of the Industry data, 66% of med spas are still single-owner and only 3% are private-equity backed (Scope Research, 2025). The category is growing fast, but most of it is growing one location at a time.
The brands trying to break out of that pattern — the IV bars, the aesthetics groups, the wellness-plus-injectables concepts — almost all run into the same wall at the same place. They get to four or five locations on charisma, a strong injector roster, and a calendar that the founder still personally watches. Then they try to add the next ten. And somewhere between five and twenty units, the wheels start coming off.
I see this pattern almost every week. The diagnosis isn’t strategy. It isn’t demand. It’s that the operating stack that worked for one or two locations is now actively working against you. We call it the duct-tape stack, and it’s the single biggest reason ambitious IV and med spa brands stall right before the valuation curve really starts to bend.
Why 5 to 20 Is the Hardest Stretch in This Industry
There’s a reason the leap from five locations to twenty is harder than the leap from one to five.
At one or two locations, almost any combination of tools will work. The founder is on-site. The lead injector knows every member by name. A shared Google Sheet, a booking app, a Stripe terminal, and a Mailchimp list can carry the business further than they should. Demand is the constraint. Marketing is the constraint. Everything else gets handled by sheer founder presence.
At twenty locations, you are running a different company. You are managing dozens of providers across multiple state regulatory regimes. You have membership revenue that has to be recognized correctly, deferred correctly, and reconciled across locations. You have inventory of controlled and prescription products that has to be tracked by site. You have marketing attribution that has to roll up across markets. And — most importantly — you have a P&L per location that an investor or acquirer will eventually open with a fine-toothed comb.
The financial reward for getting there is enormous. According to Scope Research’s 2025 M&A analysis, med spa businesses under $5M in revenue trade at 3–6x EBITDA, $5–20M businesses trade at 5–8x, businesses over $20M trade at 7–12x, and tech-enabled national platforms can reach 10–20x EBITDA (Scope Research, 2025). The same EBITDA dollar is worth two to four times as much on the other side of that gap. And the consolidation engine is real — Scope notes more than 50 announced M&A deals in each of the last two years, compared to a handful in 2019–2020 (Scope Research, 2025).
That is the prize. The 5-to-20 trap is what stands between you and it. And it almost always shows up the same way.
The Four Mechanics of Duct-Tape Drag
When a brand stalls in this stretch, it usually isn’t one big thing. It’s four smaller things compounding on each other.
1. Booking and Clinical Fragmentation
The first system that breaks is the calendar. A booking tool that worked beautifully for one location starts producing different rules at each new site. Providers double-book themselves because the intake form lives in a different system than the schedule. New consults can’t see what the membership tier entitles them to. Cancellation windows are enforced at one location and ignored at another.
The operational signal is hidden in plain sight. Provider utilization in a healthy med spa runs 70–85%, and anything under 65% means structural underbooking (Optimantra, 2026). When I audit brands stuck in the 5-to-20 zone, I almost always find at least one location running below 65% — not because demand isn’t there, but because the booking stack can’t route the demand efficiently. No-show rates of 5–10% are normal (Optimantra, 2026); duct-tape stacks routinely produce double that, because reminders, confirmations, and rescheduling each live in a different tool.
2. The Membership Leak
Memberships are now the most important revenue mechanic in the category. Roughly 85% of U.S. med spas now offer some form of membership, members visit nearly 3x more often than non-members, and they spend 35% more (4Ever Young, 2026). Industry-wide, member spending was up 35% in 2024 with a 24% jump in membership sales (4Ever Young, 2026).
And yet. Membership revenue still only accounts for about 14% of total med spa revenue industry-wide (4Ever Young, 2026). Optimantra’s 2026 benchmarks say a maturing brand should be running MRR at 20–40% of total revenue (Optimantra, 2026). The gap between what members are worth and what most operators are actually capturing is the membership leak — and it is almost entirely an operating problem.
In a duct-tape stack, the membership lives in one place, the booking in another, and payments in a third. Banked credits don’t appear at checkout. Members get charged a regular price by a front-desk associate who doesn’t see the tier. Renewals happen, but pauses and cancellations don’t get reflected in revenue recognition. Multiply that across ten or fifteen locations and you are leaking the single most valuable revenue stream you have. And you’re doing it right before the part of the growth curve where recurring revenue is the multiple expander.
3. Compliance and Clinical Variance
This is the mechanic that quietly becomes existential. The med spa industry’s growth has finally caught the attention of regulators, and the picture from inside the inspection room is sobering.
In late 2024, a joint New York City Council and Department of Consumer and Worker Protection inspection examined 15 NYC med spas between June and September. All 15 had violations. Four lost their licenses outright (NYC Council, December 2025). The specific violation breakdown is worth reading carefully: 100% performed procedures without a properly licensed operator on duty, 93% failed to display required licenses, 73% had no documented medical director oversight, 66% had chemical or fire safety violations, 60% lacked the required liability insurance, 53% had sanitation issues, 46% had product labeling violations, and 26% had unlicensed or expired employees on staff (NYC Council, December 2025).
That is one inspection sweep in one city. The state-level picture is moving just as fast. Arizona, Iowa, Indiana, and Florida all introduced new med spa bills in early 2026 covering licensing, supervision, and scope of practice. California’s 2026 laws targeting Management Services Organization (MSO) structures could change how most multi-location groups are organized. Florida’s SB 1728 may require separate pharmacy licensing for clinics handling prescriptions (4Ever Young, 2026). The FTC piled on in September 2025 with a round of non-compete warning letters specifically aimed at healthcare employers, including aesthetics groups (FTC, September 2025).
A duct-tape operating stack cannot survive this environment past a handful of locations. Provider licenses, medical director oversight, intake forms, consent documentation, and procedure logs all need to live in a system that gives you a single, defensible record per patient per visit per location. When that record is scattered across PDFs, paper charts, and three different apps, “the audit” becomes a real-time business risk — not a someday problem.
4. Attribution and Multi-Location Reconciliation
The fourth mechanic is the one that hurts the marketing function most directly, which is why I take it personally.
Most growing med spa brands spend meaningfully on local digital — Meta, Google, sometimes TikTok or YouTube creator partnerships — plus reputation, plus referrals, plus the brand-level air cover. By the time you’re at ten locations, you should be running a per-location CAC, a per-channel ROAS, and a clear view of which campaigns are filling injector schedules versus which are filling discount slots.
In a duct-tape stack, you can’t. Ad platform data doesn’t reconcile to booking data because the unique identifiers don’t match. Booking data doesn’t reconcile to revenue because membership credits and packages don’t apply cleanly. Revenue doesn’t reconcile to the GL because each location’s payment processor exports differently. The CFO gets one number, marketing gets another, ops gets a third, and the founder picks whichever one matches their gut that month.
Beneath that mess, the actual unit economics of this category are excellent when you can see them clearly. Revenue per visit runs $200–400 for general services and $400–800 for advanced treatments. Annual patient value lands between $800 and $2,000 for active patients who visit 3–6 times a year. Retention typically runs 50–70% (Optimantra, 2026). Brands that can actually measure where those numbers are coming from can put real fuel on the channels that work. Brands that can’t end up over-spending on the front of the funnel to compensate for everything that’s leaking out of the back.
What Good Looks Like: The Operating Layer Thesis
The brands that break through the 5-to-20 trap don’t just buy more software. They consolidate around a single operating layer that lets the business behave like one business across every location.
In practical terms, the operating layer has to do four jobs at once:
It has to orchestrate the customer journey end-to-end — discovery, booking, consult, treatment, follow-up, membership, renewal — without making the customer feel handoffs. When 3 in 10 med spa clients earn $100K+ household incomes (Grand View Research) and the male segment is growing roughly 5% annually (4Ever Young, 2026), the experience bar is set by the rest of the premium consumer economy — not by the med spa down the street.
It has to enforce consistency across locations and providers — the same scheduling rules, the same membership entitlements, the same intake and consent workflow, the same compliance documentation — without the founder having to police any of it manually.
It has to produce a single source of truth for finance and operations — a per-location P&L, a per-provider utilization view, a per-channel marketing performance view, a per-cohort membership view — that actually reconciles, because every system is reading from the same underlying record.
And it has to be the foundation that future technology — AI-driven personalization, predictive scheduling, automated follow-up, chair-side skin analysis — can plug into. Every analyst covering this space, from Grand View to Nextech to The Business Research Company, names integrated digital platforms and AI tooling as the operating advantage of the next five years. None of that lands cleanly on top of a duct-tape stack.
This is what we mean at MyTime when we talk about full journey orchestration instead of stitched digital duct-tape stacks. The brands that get there don’t just survive the 5-to-20 stretch. They are the ones that show up on the right side of the valuation table — the 7–12x at $20M+, and the 10–20x tech-enabled national platform (Scope Research, 2025).
The Window Is Open. The Rules Are Changing.
The macro story for IV and med spa brands has rarely been better. Demand is broadening across demographics. Younger consumers are entering the category with a “prejuvenation” mindset that compounds lifetime value over decades (4Ever Young, 2026). GLP-1 programs and wellness integration are creating new multi-visit relationships. Membership economics are getting stronger every quarter. Consolidation is accelerating, and the valuation math is rewarding scale faster than any prior cycle.
But the bar is rising at the same time. Regulators are sharpening their teeth. Investors are pricing operational sophistication into deals, not just topline growth. And the brands that win the next five years won’t be the ones with the best single location — they’ll be the ones with the operating layer that lets every location feel like the best location.
If your brand is in the 5-to-20 stretch right now, the most important question on your desk this quarter is not “how do we drive more demand?” It’s “what is actually slowing us down between the demand we already have and the revenue we should be capturing from it?”
That question almost always points at the same place. The stack.
See where your brand stands. Take the Med & IV Spa Growth Readiness Scorecard — 11 questions, about three minutes, and you’ll get a tiered diagnostic of where your operating stack is helping you grow and where it’s quietly costing you. The accompanying Growth Readiness Guide walks through what to fix first.
If you’d rather walk through it with us directly, book a strategy session with MyTime and we’ll map your operating layer to the next ten locations.
Sources: Grand View Research — Medical Spa Market; Scope Research 2025 Med Spa M&A and Valuation Multiples; Optimantra 2026 Med Spa Benchmarks; 4Ever Young — Med Spa Demand 2026; NYC Council Med Spa Inspection Report, December 2025; FTC Non-Compete Warning Letters to Healthcare Employers, September 2025.
